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Previous reports demonstrate that the α2-integrin (α2) mediates pancreatic ductal adenocarcinoma (PDAC) cell interactions with
collagens. We found that while well-diﬀerentiated cells use α2 exclusively to adhere and migrate on collagenI, poorly diﬀerentiated
PDAC cells demonstrate reduced reliance on, or complete loss of, α2. Since well-diﬀerentiated PDAC lines exhibit reduced in vitro
invasion and α2-blockade suppressed invasion of well-diﬀerentiated lines exclusively, we hypothesized that α2 may suppress the
malignant phenotype in PDAC. Accordingly, ectopic expression of α2r e t a r d e din vitro invasion and maintenance on collagenI
exacerbated this eﬀect. Aﬀymetrix proﬁling revealed that kallikrein-related peptidase-5 (KLK5) was speciﬁcally upregulated by α2,
and reduced α2 and KLK5 expression was observed in poorly diﬀerentiated PDAC cells in situ. Accordingly, well-diﬀerentiated
PDAC lines express KLK5, and KLK5 blockade increased the invasion of KLK5-positive lines. The α2-cytoplasmic domain was
dispensable for these eﬀects, demonstrating that the α2-ectodomain and KLK5 coordinately regulate a less invasive phenotype in
PDAC.
1.Introduction
Pancreatic ductal adenocarcinoma (PDAC) has one of the
highest mortality rates of all cancers; although it accounts
for only 2% of new cancer cases each year in the United
States, it is the fourth leading cause of cancer mortality
[1]. Despite this, the biology of PDAC remains poorly
understood. Mutations associated with PDAC initiation have
allowed the development of a timeline of PDAC etiology
[2]; however, factors contributing to the progression of
the disease are less well deﬁned. PDAC is associated with
prominentdesmoplasia,whichischaracterizedbysigniﬁcant
deposition of collagen I, II, and IV [3]. The collagen-
binding α2-integrin (α2) is expressed by both normal
pancreatic ductal epithelium and PDAC in situ [4, 5], and
previous studies have implicated the α2β1 integrin as the
primary collagen receptor in PDAC cells [6]. However,
immunohistochemical studies have failed to demonstrate a
consistent pattern of α2 expression in PDAC in situ [3–
5, 7, 8], complicating the determination of α2’s role in
PDAC etiology and/or progression. Importantly, while well-
diﬀerentiated,poorlymetastaticPDACcellsdemonstrateα2-
dependent responses to collagenI, poorly diﬀerentiated and
highly metastatic MIAPaCa2 cells lack collagenI interactions
altogether [6]. Moreover, α2 is associated with maintenance
of tissue architecture and cellular diﬀerentiation in other
epithelial tissues [9]. Indeed, while well-diﬀerentiated α2-
positive PDAC cells have been shown to produce extensive
primary tumors that invade locally, poorly diﬀerentiated
α2-negative PDAC cells produce small primary tumors
with prominent distant dissemination [10]. Thus, while
α2-positive pancreatic epithelial cells utilize this integrin
for collagenI interactions, overcoming this interaction may
be advantageous to malignant PDAC cells, especially in
the context of the collagen-rich desmoplastic reaction that
characterizes PDAC in situ.2 Journal of Oncology
We assessed the role of α2 in regulating the invasion
of PDAC cells in vitro. Our data demonstrate that while
α2 is a key mediator of invasion in well to moderately
diﬀerentiated PDAC cells, these cells exhibit lesser invasion
that is largely kallikrein-related peptidase (KLK) dependent.
In contrast, highly metastatic, poorly diﬀerentiated PDAC
cells demonstrate higher levels of in vitro invasion that are
largelyα2andKLKindependent.Wefurtherimplicatetheα2
ectodomain in mediating this phenotype and demonstrate
that continued exposure to collagenI exacerbates the α2-
dependent invasion-suppressor eﬀect, indicating that the
presence of α2 would be additionally inhibitory to cells
continuously exposed to the collagen-rich desmoplasia that
is characteristic of PDAC in situ.
2.MaterialsandMethods
2.1. Cells. CAPAN1, CAPAN2, BxPC3, MIAPaCa2, and
Panc1 cells were originally from ATCC, and cultured accord-
ing to ATCC. Immortalized, untransformed HPDE-E6E7c7
(HPDE) cells were provided by M. Tsao (Toronto Health
Network, ON, Canada) and cultured in keratinocyte media
supplemented with EGF and pituitary extract (Invitrogen,
Carlsbad, CA, USA). PT45P1 cells were a generous gift of H.
Kalthoﬀ (Kiel, DE), and cultured in RPMI/10% fetal bovine
serum (FBS). COLO357 cells were provided by M. Korc
(UCI, Irvine, CA, USA) and cultured in DMEM/10% FBS.
Serum-free (SF) medium consisted of all components except
serum, as appropriate for the cell line, supplemented with
0.5% bovine serum albumin (BSA). Cell line diﬀerentiation
characteristics are described in Supplemental Table S1 avail-
able online at doi: 10.1155/2011/365651.
2.2. Antibodies and Reagents. Function-blocking anti-
integrin antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA) or Chemicon/EMD (San Diego,
CA, USA) and include: α1(5E8D9); α2(P1H5); α3(P1B5);
β1(P4C10). Anti-α2 mAb (611016) used for immunoblot-
ting and IHC was from BD Transduction Laboratories
(Lexington, KY). Goat anti-hKLK5 (AF1108) and anti-
hKLK6 (AF2008) aﬃnity puriﬁed pAbs were from R&D
Systems (Minneapolis, MN). Anti-actin was from Sigma
(St. Louis, MO). Puriﬁed bovine collagenI (Purecol) was
from Advanced Biomatrix (San Diego, CA, USA). Peptide-
based kallikrein inhibitor (RP10161) was from GenScript
(Piscataway, NJ, USA). HRP- and FITC-conjugated second-
ary antibodies were from Jackson Immunochemicals (West
Grove, PA, USA). pGEX vector encoding GST-tagged
tenascin FNIII domain was generously provided by K.
Crossin (TSRI, La Jolla, CA, USA), and produced as
described previously [11].
2.3. Expression Constructs and Transfection/Selection.
pBS(KS+) containing wildtype human α2-integrin CDS
(clone 2.72F) was from ATCC. The α2C D Sw a se x c i s e d
with KpnI and ligated into pCDNA3.1(zeo) to create
pCDNA3.1/α2. The α2Δcyto insert was created by PCR
of pCDNA3.1/α2 with T7 sequencing primer (forward)
and α2Δcyto/XbaI primer (Supplemental Table S2), which
contains a 3
  stop codon and XbaI site. The resulting product
was digested with XbaI and shuttled through pEF4a. The
insert was excised from pEF4a with KpnI and NotI and
inserted into these sites on pCDNA3.1(zeo). pCDNAIneo/
α9DM1 and pCDNAIneo/α9α2 were generously provided
by D. Sheppard (UCSF, San Francisco, CA, USA), and have
been described previously [11]. KLK5 and KLK6 CDS’s were
ampliﬁed from COLO357 cDNA using primers containing
engineered XbaI restriction sites (Supplemental Table S2).
The resulting products were cut with XbaI and inserted
into the XbaI site of pCDNA3.1(zeo) immediately upstream
of an IRES linked to a hygromycin phosphotransferase
gene (base construct described previously; [12]). Sequences
were veriﬁed at the Moores UCSD Cancer Center DNA
Sequencing Shared Resource. MIAPaCa2 cells were trans-
fected according to the manufacturer’s instructions for
Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA). MP2/
α2a n dM P 2 / α2Δcyto cells were panned on plates coated
with 25μg/mL collagenI and blocked with 5% BSA/PBS,
and selected with zeocin. MP2/α9DM1 and MP2/α9α2c e l l s
were panned and maintained in the presence of G418 on
10μg/mL GST-TnFNIII. KLK-expressing cells were selected
with hygromycin. Stable cell populations were maintained
in the presence of selection agent. Transient transfections
employed cotransfection of pEF4-LacZ and x-gal staining to
identify transfected cells.
2.4. Immunoblotting. Cells were lysed on the plate in NP40
lysis buﬀer (50mM Tris pH 7.4, 150mM NaCl, 1% NP-
40) containing Complete Protease Inhibitor Cocktail supple-
mented with 10mM PMSF, 1mM NaF, and 10mM Na3VO4.
Samples were prepared and analyzed as described previously
[12].
2.5. Enzyme-Linked Immunosorbent Assay (ELISA). Equal
volumes of conditioned medium were coated in triplicate
onto 96-well microtiter plates. Wells were blocked with
0.5% gelatin prior to incubation with primary antibody.
Wells were washed with TBS-T and incubated with HRP-
conjugated secondary antibody. Antibody complexes were
detected with the peroxidase substrate SureBlue TMB (KPL;
Gaithersburg, MD). The reaction was stopped with 0.2N
HCl and absorbance read at 450nm.
2.6. Flow Cytometry. Flow cytometry was performed on
a FACScalibur (BD Biosciences, Bedford, MA, USA) at
the Moores UCSD Cancer Center Flow Cytometry Shared
Resource. Gates were set with cells treated with FITC-
conjugated secondary antibody alone, and 5μg/mL propid-
ium iodide was included to exclude dead and dying cells.
2.7. Adhesion Assay. Subconﬂuent cells were seeded in SF-
media at 2.5 × 105 cell per 48-well nontissue culture-treated
plate that had been coated with 25μg/mL (unless indi-
cated otherwise) collagenI and blocked with 5% BSA/PBS.
Cells were allowed to adhere for 45min (unless otherwise
indicated) before washing, staining with 1% Toluidine Blue
and manual enumeration or extraction of dye with 10%Journal of Oncology 3
acetic acid and quantitation of absorbance at 595nm.
Where indicated, cells were preincubated with antibodies
(50μg/mL) for 5min before seeding into wells.
2.8. Migration Assay. Millicell sterile culture plate inserts
(8μm pore; Millipore Corp., Billerica, MA, USA) were
coated on the underside with 20μg/mL collagenI prior to
insertion into culture plates containing SF media. Cells
(2.5 × 105) were added in SF-media to the upper chamber
in the presence or absence of 50μg/mL function-blocking
antibodies at 37◦C. Inserts were ﬁxed at the indicated
times, stained with 1% Toluidine Blue, and unmigrated cells
removed and migrated cells enumerated. Where indicated,
antibodies (50μg/mL) were present in both chambers.
2.9. Invasion Assay. Subconﬂuent cells (2.5 × 105)w e r e
seeded in SF-media into BioCoat Growth Factor-Reduced
Matrigel Invasion Chambers (BD Biosciences, Bedford, MA,
USA) in wells containing full growth media. Chambers
were incubated at 37◦C for 24h (48h for COLO357 cells),
or as indicated before ﬁxing, staining with 1% Toluidine
Blue, removal of uninvaded cells and manual enumeration.
Whereindicated,antibodies(50μg/mL)werepresentinboth
chambers.
2.10. Reverse Transcription-PCR. cDNA was synthesized
from 1μg of total RNA using oligo-dT primer. PCR was
performed on 1μL of total cDNA using primers described
in Supplemental Table S2.
2.11. Immunohistochemistry. Tissue samples were obtained
under approved Institutional Review Board protocol from
the UCSD Dept. of Pathology archives. Samples were
deparaﬃnized, rehydrated, and incubated with 1% H2O2
to inactivate endogenous peroxidases. Slides were quenched
with 50mM glycine, blocked with 2% horse serum/5%
BSA/phosphate-buﬀeredsaline (PBS),pH 7.4,and renatured
using Target Retrieval Solution (DAKO North America;
Carpinteria, CA, USA) prior to incubation with anti-α2
or anti-hKLK5 pAb at 2.5μg/mL. Slides were washed and
biotinylated antimouse or antigoat applied according to the
VectaStain Elite ABC Kit (Vector Labs; Burlingame, CA,
USA). Sections were developed with DAB, counterstained
with hematoxylin, dehydrated and mounted.
2.12. Aﬀymetrix Gene Array Analysis. Detailed in the Sup-
plementary Material section along with tables of represent-
ative gene changes (Supplemental Tables S3 and S4). The
full set of array data is available in the GEO repository via
Accession no. GSE18277 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?token=zreftooauqiuupq&acc=GSE18277).
2.13. Statistics. Gene array statistics are described in Sup-
plemental Methods. Adhesion, migration and invasion were
analyzed by two-tailed Students t-test.
3. Results
3.1. Pancreatic Collagen-Binding Integrin Expression Reﬂects
Diﬀerentiation State. Flow cytometric analysis of pancreatic
cells that span the spectrum of diﬀerentiation (see Supple-
mentalTableS1)demonstratedadistinctpatternofcollagen-
interactive integrin surface expression in vitro (Figure 1(a)).
All cells express signiﬁcant α3 integrin. However, although
untransformed HPDE and well-diﬀerentiated CAPAN1 (G1)
and CAPAN2 (G1) cells demonstrated signiﬁcant α2e x p r e s -
sion and no α1 expression, moderately diﬀerentiated BxPC3
(G2) and COLO357 (G2) cells express signiﬁcant α2a n d
marginal α1. In contrast, poorly diﬀerentiated PT45P1
(G3/G3+) cells express signiﬁcant levels of both α1a n dα2,
while very poorly diﬀerentiated MIAPaCa2 (G3+) cells lack
bothintegrinsaltogether.Thecollagen-bindingintegrinsα10
and α11 were not studied due to their restricted expression
and the fact that all collagenI interactions in our cells could
be accounted for by α1a n dα2. These data demonstrate the
diﬀerential expression of collagen-interactive integrins in a
manner coincident with diﬀerentiation.
3.2. Poorly Diﬀerentiated PDAC Cells Demonstrate Reduced
Reliance or Complete Loss of α2 Integrin Interactions.
Untransformed HPDE cells as well as well- and mod-
erately diﬀerentiated PDAC cells demonstrated complete
reliance on the α2β1 integrin for adhesion and migration
on collagenI (Figures 1(b) and 1(c)). In contrast, α2-
blockade of poorly diﬀerentiated PT45P1 cells had little
eﬀect on their adhesion to collagenI. Indeed, while α1-
(Figure 1(b))a n dα3-blockade (not shown) similarly failed
to suppress binding, combination of α1- and α2-function-
blocking antibodies almost completely abrogated PT45P1
adhesion to collagenI (Figure 1(b)). Although α2-blockade
signiﬁcantly suppressed PT45P1 migration on collagenI,
combinedblockadewithα1pr omotedenhanc edsuppr ession
(Figure 1(c)), further demonstrating the reduced reliance of
these poorly diﬀerentiated cells on α2 for collagen inter-
actions. Importantly, very poorly diﬀerentiated MIAPaCa2
cells demonstrate no adhesion or migration on collagenI
(Figures 1(b) and 1(c)), commensurate with their lack of α1
and α2 integrin expression and similar to previous reports
[6].
3.3. Ectopic Expression of α2 in MIAPaCa2 Cells Recapitulates
Collagen Interactions. Since MIAPaCa2 cells lack α2 integrin
and do not adhere to collagenI, we ectopically expressed α2
under a viral (cytomegalovirus) promoter and maintained
one population on collagenI (MP2-α2/CI), and one popu-
lation in standard tissue culture (MP2-α2/TC) (Figure 2(a)).
MP2-α2/CIcellsdemonstratesigniﬁcantlyhigherα2integrin
surface levels than MP2-α2/TC cells (mean FL1 77.0 versus
31.3) (Figure 2(b)), and this higher surface expression is
reﬂected in transcript as well (Figure 2(c)(i)). Similarly,
whereas mock and α2 transfectants demonstrate identical
β1 levels in culture, repeated passage on collagenI promotes
signiﬁcantly higher levels of surface β1 subunit (mean FL1
136.7 versus 79.3) (Figure 2(b)), likely due to the require-
ment for heterodimerization to facilitate translocation of4 Journal of Oncology
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Figure 1: PDAC integrin expression and utilization reﬂects cellular diﬀerentiation. (a) Flow cytometric analysis of α1, α2, or α3s u r f a c e
expression in a spectrum of pancreatic ductal cells including untransformed (HPDE), well-(CAPAN1 and CAPAN2), moderately (BxPC3,
COLO357) and poorly diﬀerentiated PDAC (PT45P1 and MIAPaCa2) (see Supplemental Table S1 for cell characteristics). Secondary
antibody controls, solid. (b) Adhesion of the cells in (a) to 25μg/mL collagenI for 45 minutes in the presence or absence of function-
blocking antibodies to the indicated integrins, as described in Materials and Methods. (c) Serum-free migration (16h) through Transwell
inserts coated on the underside with 20μg/mL collagenI in the presence or absence of function-blocking antibodies as in (b).Journal of Oncology 5
the α2 subunit to the cell surface. All cells express identical
α3l e v e l sa n dl a c kα1 expression (Figures 2(b) and 2(c)(i)),
indistinguishable from the parental cells (Figure 1(a)). Since
integrins are often retained in an intracellular pool, the
diﬀerential surface expression observed may not reﬂect
diﬀerent total levels of protein, but rather the preferential
export of α2β1 to the cell surface in response to the demands
of continued growth on a collagen substratum. However,
immunoblotting of whole cell lysates demonstrated signif-
icantly more α2 in the MP2-α2/CI cells than MP2-α2/TC
cells(Figure 2(c)(ii)).Thisdiﬀerentialexpressionwasnotthe
resultofselectingahigh-expressingpopulationduringinitial
panning, since both populations were derived from the same
original panning process (Figure 2(a)). Moreover, the active
regulation of α2 levels by exposure to collagenI is further
demonstrated by the reduction in α2 expression noted upon
removal of MP2-α2/CI from collagenI and culture under
standard conditions as well as the heightened expression that
results from repassaging the cells onto a collagenI-coated
substratum (Figure 2(d)(i, ii)).
3.4. Diﬀerential α2 Expression Promotes Dose-Dependent
CollagenIInteractionandSuppressionofInvasion. BothMP2-
α2/TC and MP2-α2/CI cells demonstrate complete reliance
on integrin α2β1 for adhesion to collagenI (Figure 3(a)(i)).
However, the higher α2 expression of MP2-α2/CI cells
translates to more rapid and more complete collagenI adhe-
sion (Figure 3(a)(ii)), and a requirement for less collagenI
to achieve maximal adhesion (Figure 3(a)(iii)). Moreover,
MP2-α2/CI cells transitioned to standard tissue culture
conditions demonstrated a progressive loss of this enhanced
adhesiveness to collagenI (Figure 3(a)(iv)). The elevated α2
expression and collagenI adhesion of the MP2-α2/CI cells
alsotranslatedtoahigherrateandoveralllevelofhaptotactic
migration on collagenI (Figure 3(b)); however, MP2-α2/CI
cells actually demonstrated a reduced rate of invasion com-
pared to MP2-α2/Mock (Figures 3(c) and 3(d))a n dM P 2 -
α2/TC (Figure 3(d)). Importantly, MP2-α2/TC and MP2-
α2/CI cells demonstrated a time-dependent eﬀect whereby
more invasion suppression was achieved after prolonged
culture, culminating in a maximum of 40% reduction for
MP2-α2/TC cells and >90% for MP2-α2/CI cells versus
MP2-α2/Mock cells (Figure 3(d)). Although these data and
those shown in Figures 2(c) and 2(d) could be interpreted to
mean that higher levels of α2 merely translate to enhanced
adhesion to Matrigel, thus resulting in decreased invasion,
the opposite is actually true, as MP2-α2/TC and MP2-
α2/CI adhesion to Matrigel is actually retarded versus MP2-
α2/mock cells (Figure 3(e)). As might be predicted from the
time-dependent nature of the anti-invasive eﬀect, transient
expression of α2 did not retard the invasion of parental
MIAPaCa2 cells (Figure 3(d), right panel), although these
cells expressed similar levels of surface α2a sM P 2 - α2/TC and
MP2-α2/CI cells (Figure 3(f)) and exhibited signiﬁcant de
novo adhesion to collagenI (Figure 3(g)).
3.5. α2 Regulates the Expression of Invasion-Related Gene
Products That Retard Invasion In Vitro. The data shown
in Figure 3(d) demonstrate the requirement for long-term
expression of the α2 integrin to achieve maximal invasion-
suppressive eﬀects, and the fact that transient expression of
α2h a dn oe ﬀect on invasion. Since this eﬀect is not due
to increased Matrigel adhesion (Figure 3(e)), this suggests
the need for gene expression changes to eﬀect the invasion
suppression phenotype of α2. Therefore, we performed
Aﬀymetrix global gene expression analysis to determine
transcripts regulated by α2 expression (α2/TC), or α2
expression coupled with constitutive engagement (α2/CI).
Over 6,000 transcripts were diﬀerentially expressed at a false
discovery rate (FDR) ≤0.01 (Figure 4(a)(i), Supplemental
Table S3). Among the most prominently aﬀected were
kallikrein-related peptidases (KLKs) 5, 6 and 7, which have
a relatively ill-deﬁned relationship to the regulation of cell
migrationandinvasion.Weveriﬁedtheupregulationofthese
KLK transcripts in MP2-α2/TC cells, and the exacerbated
expression in MP2-α2/CI cells (Figure 4(a)(ii)). We further
veriﬁed the expression of KLK-5, 6 and 7 transcripts by
untransformed and well-to moderately diﬀerentiated PDAC
cell lines, to the exclusion of poorly diﬀerentiated PDAC
lines (Figure 4(a)(iii)). The sole exception to this pattern was
moderately diﬀerentiated (G2) BxPC3 cells, which did not
express detectable KLK-5, 6 or 7 transcript. In allcases, KLK-
5,6,and7werecoordinatelyexpressed;thatis,eitherallthree
were expressed or none were. Aﬀymetrix demonstrated that
no other KLKs were expressed by these cells. Importantly,
blockade of KLK activity with a peptide-based inhibitor
enhanced the invasion of endogenously KLK-positive cells
as well as the MP2-α2/CI cells, to the exclusion of KLK-
negative cells (Figure 4(b)), and KLK blockade had a similar
eﬀect on haptotactic migration of KLK-positive cells towards
collagenI (Figure 4(c)).
The enzymatic speciﬁcities of KLK5 and KLK6 diﬀer
dramatically from KLK7. The major determinant of speci-
ﬁcity for KLK-5, 6, and 7 is the S1 pocket, demonstrating
primary speciﬁcity deﬁnition at the P1 position, with
additional speciﬁcity preference dictated by the P2 position;
for diﬀerent reasons, the P3 and P4 positions are relatively
unimportant in deﬁning the speciﬁcities of KLK-5, 6 and 7
[13].Assuch,KLK5andKLK6exhibittrypsin-likespeciﬁcity
with a strong preference for Arg at the P1 position of
substrates (KLK5, R   K, but not Y or F; KLK6, R   A,
M > K), while KLK7 exhibits a unique chymotrypsin-like
speciﬁcity for Tyr at P1 (Y > A, M ≫ F, R, K), and also at P2
(Y > L, T, M, F) [13]. Therefore, it is highly unlikely that the
peptide-based inhibitor used in Figure 4 (PFR|SVQ) would
aﬀect KLK7, but the Arg at the P1 position of this peptide
wouldserveasrelativelyoptimalforbindingtothesubstrate-
binding S1 pockets of KLK5 and KLK6.
Based on this information, we further assessed the
production of KLK5 and KLK6 by the spectrum of cells
that we had veriﬁed at the transcript level. Consistent with
their RNA proﬁle, untransformed HPDE and all well- to
moderately diﬀerentiated PDAC except BxPC3 expressed
signiﬁcant quantities of both KLK5 and KLK6 (Figure 5(a)).
Total cellular α2 expression is similar between the cell lines,
similartothesurfaceexpressionshowninFigure 1(a).Again,
poorly diﬀerentiated cells proved negative for both KLK56 Journal of Oncology
Transfect MIAPaCa2 cells with
pCDNA3.1/α2o re m p t yv e c t o r
P7
P0
P4
P1
P3
Add zeocin
Passage cells to culture plate coated
with collagenI (α2-negative cells
washed away after 1h)
Use ﬁnal cell populations in assays
Uncoated tissue
culture plate
culture plate
CollagenI-coated
Repassage cells to collagenI-coated
tissue culture plate
Passage cells to collagenI-coated or
uncoated tissue culture plate
Verify expression by FACS α2
(a)
100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104
0
640
1280
1920
2560
3200
0
680
1360
2040
2720
3400
0
860
1720
2580
3440
4300
0
860
1720
2580
3440
4300
FL1-FITC FL1-FITC
C
o
u
n
t
s
C
o
u
n
t
s
C
o
u
n
t
s
C
o
u
n
t
s
α1 α2
α3 β1
Mock
α2/TC
α2/CI
(b)
α1
β1
α3
α2
GAPDH
M
o
c
k
α
2
/
T
C
α
2
/
C
I
(i)
α2
M
o
c
k
α
2
/
T
C
α
2
/
C
I
Actin
α
2
/
O
ff
C
I
(
w
1
1
)
) i i (
(c)
1 5 25 35 15
4
4
8 2
2
1
1
Oﬀ CI (wks) On CI (wks)
Weeks
+ invasion analysis
∗ CI adhesion comparison
121819
···
···
+ + +
∗∗∗
48 24 2 1 12 18
α
2
/
C
I
α2
Actin
OﬀCI
OnCI
(i) (ii)
(d)
Figure 2: Reexpression of α2 in MIAPaCa2 Cells. (a) Expression and selection scheme. (b) Flow cytometric analysis of cell surface α1, α2,
α3a n dβ1 integrin expression in MP2-mock, MP2-α2/TC, and MP2-α2/CI cells. Secondary antibody controls (solid) are overlapped. (c)
Integrin levels were assessed at the transcript (i) and total protein level (ii) using RT-PCR and immunoblotting as described in Materials
and Methods. GAPDH and actin, controls. (d) The eﬀect of maintenance on collagenI was assessed by replating cells grown on collagenI for
an extended period into standard tissue culture conditions and then returning those cells to collagenI culture at the indicated times (i). (ii)
Lysates were immunoblotted for total α2 expression. Actin, control.
and KLK6. We further veriﬁed the secretion of KLK5 and
KLK6 in the cells that showed protein at the whole cell lysate
level (Figure 5(b), left panel), as well as in the MP2-α2/TC
and MP2-α2/CI cells, to the exclusion of the MP2-mock
cells (Figure 5(b), right panel). These data demonstrate that
KLK5/6 expression correlates well with grade, is driven by
stable α2 reexpression in MP2 cells, and further indicate
the availability of α2-positive cells suitable for engineering
ectopic KLK expression (i.e., BxPC3).
ToassesstheKLKinvolvedinregulatingtheinvasivephe-
notype of these cells, we stably transfected BxPC3 cells with
hKLK5 (Bx/KLK5) or hKLK6 (Bx/KLK6) under the control
of a CMV promoter and linked via an IRES to a hygromycin
phosphotransferase gene, which links hygro-resistance to
KLK expression. Stable heterogenous populations were
selected and found to secrete similar quantities of KLK5 and
KLK6 as endogenously KLK5/6-positive cells (Figure 5(c)).
Mock-transfected (Bx/mock) cells resistant to hygromycin
did not secrete detectable KLK5 or KLK6. We further found
that Bx/KLK5 cells demonstrated reduced in vitro invasion
(Figure 5(d),l e f tp a n e l )a n dh a p t o t a c t i cm i g r a t i o nt o w a r d s
collagenI (Figure 5(d), right panel) compared to Bx/mock
cells. Consistent with the ﬁndings of a prior report [14],
Bx/KLK6 cells actually invaded better than Bx/mock cells.
Importantly, the KLK inhibitor reversed both phenotypes,
demonstrating the speciﬁcity of the eﬀect and the eﬃcacy
of the inhibitor against both KLK5 and KLK6 and further
suggesting that the net eﬀects of KLK5 outweigh those of
KLK6 in this cell system. Having identiﬁed KLK5 as the
KLK responsible for at least part of the observed anti-
invasive phenotype, we stably transfected the α2-negative
parental MP2 cells with hKLK5 (MP2/KLK5 cells) or empty
vector (MP2/mock cells). Stable heterogeous populations
were selected and MP2/KLK5 cells were found to secrete
quantities of KLK5 similar to endogenously positive as well
as stable Bx/KLK5 cells (Figure 5(e)). MP2/mock cells did
not secrete KLK5 and neither population secreted KLK6.
Surprisingly, MP2/KLK5 cells did not demonstrate reduced
in vitro invasion versus MP2/mock cells, nor was their
invasion aﬀected by the KLK inhibitor (Figure 5(f)). Based
on these data, we questioned whether α2 expression was
necessary for the KLK5-dependent anti-invasive phenotype.
It should be noted that stable expression of KLK5 and KLK6
did not signiﬁcantly aﬀect the expression of α2i nB x P C 3Journal of Oncology 7
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Figure 3: Reexpression of α2 recapitulates collagen interactions and retards invasion. (a) (i) Adhesion of MP2-α2/TC and MP2-α2/CI cells
in the presence or absence of function-blocking antibodies directed towards the indicated integrins. (ii) Time course of adhesion of MP2-
α2/TC and MP2-α2/CI cells. (iii) Titration of collagenI adhesion of MP2-α2/TC and MP2-α2/CI cells. (iv) Adhesion of MP2-mock and
MP2-α2/TC cells to collagenI was compared to the collagenI adhesion of MP2-α2/CI cells that had been grown for the indicated times oﬀ
collagenI (OﬀCI). (b) Haptotactic migration time course of MP2-α2/TC and MP2-α2/CI cells on collagenI. (c) In vitro invasion of MP2-
mockandweek10MP2-α2/CIcells.(d,leftpanel)InvasionofMP2-mockandMP2-α2/TCcellswascomparedwithMP2-α2/CIcellsafterthe
indicated weeks of culture. (d, right panel) Parental MIAPaCa2 cells were cotransfected pEF4/LacZ reporter and either empty pCDNA3.1
vector (Mock) or the pCDNA3.1/α2 construct, and invasion of LacZ-positive cells examined 48 hours later. (e) Adhesion of MP2-mock,
MP2-α2/TC, and MP2-α2/CI cells to a titration of Matrigel. (f) FACS analysis of α2 expression by transiently transfected MP2 cells (α2/48h)
versus stable MP2-α2/TC and MP2-α2/CI cells. (g) CollagenI (CI) and ﬁbronectin (FN) adhesion of mock- or α2-transfected MP2 cells at
48h versus stable MP2-mock and MP2-α2/TC cells.
(Figure 5(g)) or MP2 cells, which remained α2-negative
(not shown). To determine if transient expression of α2
could rescue the KLK5 phenotype, we transfected stable
MP2/KLK5 cells with the α2 expression construct or empty
vector.After48htheα2-transfectedMP2/KLK5cellsdemon-
stratedidenticalinvasiontomock-transfectants(Figure 5(h),
left panel); however, the transfected cells demonstrated
signiﬁcantdenovomigrationtowardscollagenI(Figure 5(h),
right panel). These data suggest that long-term expression of
α2 is likely required for the full phenotype, either directly
or indirectly. We did not assess stable expression of α2i n
the MP2/KLK5 cells, since stable α2 expression would lead
to the upregulation of KLK-5, 6, and 7, as shown previously
(Figures 4(a)(ii) and 5(b)).
Previous immunohistochemical studies have failed to
demonstrate a consistent pattern of α2 expression in PDAC
in situ [3–5, 7, 8]. To assess the relevance of our ﬁndings with
regard to the human condition, we assessed the expression
of α2 and KLK5 in patient samples spanning the spectrum
of normal to well-, moderately, and poorly diﬀerentiated
PDAC. Consistent with prior reports, we found that α2i s
strongly and speciﬁcally expressed in ductal epithelial cells8 Journal of Oncology
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Figure 4: Stable α2 reexpression upregulates KLK-5, 6, and 7, which are expressed in a diﬀerentiation-dependent manner and regulate
in vitro invasion and collagenI migration. (a) (i) Heatmap presentation of identiﬁed gene products. (ii) RT-PCR analysis of Aﬀymetrix-
identiﬁed candidates KLK-5, 6, and 7 in MP2-mock, MP2-α2/TC and MP2-α2/CI cells. GAPDH, control. (iii) RT-PCR analysis of KLK-5,
6 and 7 expression in a spectrum of pancreatic cells including: untransformed (HPDE), well-(CAPAN1 and CAPAN2), moderately (BxPC3
and COLO357) and poorly diﬀerentiated PDAC (Panc1 and PT45P1) (see Supplemental Table S1 for information on cellular grade and
origin). GAPDH, control. (b) Invasion analysis of the indicated cells in the presence or absence of KLK inhibitor (KLKi). (c) CollagenI
migration analysis of the indicated cells in the presence or absence of KLK inhibitor (KLKi).
of the normal pancreas, including large and small ducts
and the ductules servicing acinar clusters (Figures 6(A)
and 6(a)). Expression of α2 is uniformly maintained in
well diﬀerentiated PDAC lesions (Figures 6(B) and 6(b))
but progressively lost in more poorly diﬀerentiated cells,
even those adjacent to better diﬀerentiated PDAC cells
(Figures 6(C) and 6(c)). Importantly, α2-reduced/negative
cells were observed invading structures including the wall of
the duodenum (Figures 6(D) and 6(d)) and regional lymph
nodes (Figures 6(E) and 6(e)), adjacent to α2-positive well-
to moderately diﬀerentiated PDAC that failed to invade these
structures. Indeed, while we observed no heterogeneity of α2
staining in normal (n = 8) and well/moderately diﬀerenti-
ated samples (n = 16), we observed reduced staining of α2i n
62.5% of poorly diﬀerentiated samples (n = 8). Consistent
withapriorreport[15],wefoundstrongexpressionofKLK5Journal of Oncology 9
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Figure 5:KLK5mediates an anti-invasion phenotype in α2-expressingPDACcells invitro. (a) Immunoblotanalysis of theindicated cells for
expression of KLK5, KLK6, and α2 integrin. Actin, loading control. (b) ELISA of KLK5 and KLK6 secretion into culture media conditioned
by the indicated cells. (c) ELISA analysis of KLK5 and KLK6 secretion by engineered BxPC3 cells stably transfected with KLK5 (Bx/KLK5)
and KLK6 (Bx/KLK6) versus hygromycin-resistant mock transfectants (Bx/mock). (d) Invasion (left panel) and collagenI migration (right
panel) analysis of the indicated stable BxPC3 populations in the presence or absence of KLK inhibitor (KLKi). (e) ELISA analysis of KLK5
secretion by engineered MP2 cells stably transfected with KLK5 (MP2/KLK5) versus hygromycin-resistant mock transfectants (MP2/mock).
αKLK6, control. (f) Invasion analysis of the indicated stable MP2 cells in the presence or absence of KLK inhibitor (KLKi). (g) Immunoblot
analysis of total α2 expression by the indicated stable BxPC3 populations. Actin, control. (h) Invasion (left panel) and collagenI migration
(right panel) analysis of the stable MP2/KLK5 cells transiently transfected with α2( α2-48h) or empty vector (mock).
in the acinar cells of the normal pancreas, but also in the
large and small ducts as well as the ductules servicing acinar
clusters (Figures 6(F) and 6(f)). Similar to our observations
with α2, KLK5 expression was uniformly maintained in
well-diﬀerentiated PDAC lesions (Figures 6(G) and 6(g)),
but progressively lost in more poorly diﬀerentiated cells,
even those adjacent to better diﬀerentiated PDAC cells
(Figures 6(H) and 6(h)). Importantly, staining of serial
sections demonstrated that KLK5-positive (Figure 6(I, J))
clusters of interactive cells were also α2-positive (Figures 6(i)
and 6(j)), while poorly diﬀerentiated/anaplastic PDAC cells
invading into the stroma demonstrated signiﬁcantly reduced
expression or loss of KLK5 (Figures 6(I) and 6(J)) and α2
(Figure 6(i) and 6(j)).
From a mechanistic standpoint, we questioned which
region of α2 is responsible for the observed gene regulation
and anti-invasive eﬀects. To address this question, we
generated a cytoplasmic deletion mutant (α2Δ) and stably
expressed it in MIAPaCa2 cells (MP2-α2Δ). These cells were
maintained under drug selection on collagenI. Similar to10 Journal of Oncology
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Figure 6: α2 and KLK5 are expressed in normal pancreatic ductal epithelium and reduced or absent in poorly diﬀerentiated PDAC. (Upper
Panels) (A) Normal pancreas stained for α2 showing positive ducts and ductules. (a) Higher power image of (A). (B) Well-diﬀererentiated
PDAC showing α2 positivity. (b) Higher power image of (B). (C) Moderate- to poorly diﬀerentiated PDAC showing reduction/loss of α2
i nt h em o r ep o o r l yd i ﬀerentiated cells. Asterisk denotes a benign reactive duct within the tumor region. (c) Higher power image of (C).
(D) Poorly diﬀerentiated α2-reduced/negative PDAC cells (black arrowhead) invading the wall of the duodenum (DW) with adjacent α2-
positive noninvading well-diﬀerentiated ducts. (d) Higher power image of (D). (E) Poorly diﬀerentiated α2-reduced/negative PDAC cells
(black arrowhead) invading the lymph node (LN), with adjacent α2-positive non invading well-diﬀerentiated ducts. (e) Higher power image
of(E).(Lowerpanels)(F)NormalpancreasstainedforKLK5showingductsandductulespositive(inadditiontoacinarcellsandsomesignal
in islets). (f) Higher power image of (F). (G) Well-diﬀerentiated ducts showing KLK5 positivity. (g) Higher power image of (G). (H) Well- to
moderately diﬀerentiated KLK5-positive ducts with adjacent less diﬀerentiated, KLK5-reduced/negative cells (black arrowhead). (h) Higher
power image of (H). (I) A ﬁeld of poorly diﬀerentiated/anaplastic PDAC cells (black arrowhead) with adjacent clusters of KLK5-positive
cells (white arrowheads); low power. (i) α2 staining of a serial section of (I). (J) Higher power image of KLK5 staining in I. (j) Higher power
image of α2 staining in (i).Journal of Oncology 11
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Figure 7: The α2 ectodomain regulates expression of KLK-5, 6, and 7, the combination of which mediates an anti-invasion phenotype in
vitro. (a) (i) CollagenI adhesion of MP2-mock and MP2-α2/TC cells compared with MP2-α2Δ cells. (ii) Invasion analysis of MP2-mock
versus MP2-α2Δ cells (left panel), or MP2-mock versus MP2-α9α2a n dM P 2 - α9DM1 cells (right panel). (b) (i) Heatmap presentation of the
probeset shown in Figure 4(a)(i) in MP2-α2Δ and MP2-α9α2 cells. (ii) RT-PCR veriﬁcation of KLK-5, 6 and 7 expression in MP2-α2Δ and
MP2-α9α2 cells. (c) (i) Invasion of the indicated cells in the present or absence of function-blocking anti-α2 antibody. (ii) Model of PDAC
invasion status based on α2-dependence and KLK5 expression status.
MP2-α2/CI cells, prolonged growth of MP2-α2Δ cells on
collagenI yielded a collagenI-adhesive phenotype superior to
MP2-α2/TC cells (Figure 7(a)(i)). To complement the α2Δ
construct, we stably expressed a α9α2 chimera that encodes
the α9 extracellular and transmembrane domains linked to
the cytoplasmic domain of the α2 integrin in MIAPaCa2
cells (MP2-α9α2). To control for potential eﬀects of the
α9 ectodomain, we also expressed a cytoplasmic-deleted α9
(MP2-α9DMI). These cells were panned and maintained
under drug selection on a recombinant FNIII domain of
tenascin (TnFNIII), a speciﬁc substrate of the α9 integrin
[11]. Parental MIAPaCa2 cells lack endogenous α9 integrin
expression, anddo notadheretoTnFNIII (notshown).MP2-
α2Δ cells demonstrated >75% invasion suppression, versus12 Journal of Oncology
MP2/Mock cells (Figure 7(a)(ii)), and while MP2-α9α2c e l l s
demonstrated similar invasion suppression, part of this
phenotype is likely due to the extracellular domain of the α9
integrin, which itself promoted ∼43% invasion suppression
(MP2-α9DM1). Thus, the α2 cytoplasmic domain may only
be responsible for 32% invasion suppression in these cells.
Aﬀymetrix analysis of the MP2-α2Δ and MP2-α9α2c e l l s
demonstrated that many of the gene products identiﬁed in
Figure 4(a)(i) and Supplemental Table S3 were diﬀerentially
regulated by either the α2e c t o d o m a i n( α2Δ) or cytoplasmic
domain (α9α2); however, some products were not aﬀected
by expression of either construct or were aﬀected by both
(Figure 7(b)(i), Supplemental Table S4). Importantly, KLK-
5, 6, and 7 wereupregulated in MP2-α2Δ cells in comparison
to MP2-α9α2 cells (Figure 7(b)(ii)).
These data demonstrate the regulation of KLK expres-
sion by the α2 integrin, and the manifestation of a
reduced invasion phenotype by the coordinated input of
both players. Accordingly, very poorly invasive COLO357
cells that demonstrated KLK-positivity (Figures 4(a)(iii),
5(a),a n d5(b))a n dan e g a t i v ee ﬀect of KLK’s on invasion
(Figure 4(b)) also demonstrate complete reliance on α2
integrin for invasion in vitro (Figure 7(c)(i)). BxPC3 cells
also demonstrate complete inhibition of invasion by α2-
blockade (Figure 7(c)(i)); however, they lack KLK-5, 6,
and 7 expression (Figures 4(a)(iii), 5(a),a n d5(b))a n d
are not aﬀected by KLK blockade (Figure 4(b)), which
manifests as moderate in vitro invasion. In contrast, highly
invasive PT45P1 and MIAPaCa2 cells demonstrate loss of
reliance on α2, or complete lack of eﬀect of α2-blockade on
invasion, respectively (Figure 7(c)(i)). Importantly, however,
the reduced invasion of MP2-α2/CI cells is completely
suppressed by α2-blockade. The speciﬁc role of KLK5
in regulating these phenotypes has been demonstrated in
Figure 5. These parameters have been summarized in the
model shown in Figure 7(c)(ii).
4. Discussion
In this study, we demonstrate the regulation of KLK5 expres-
sion by the α2 integrin and the manifestation of a reduced
invasionphenotypebythecoordinatedinputofbothplayers.
Assuch,wepropose thattheinvasionofPDACcellsisatleast
partly a balance between their reliance on α2f o rc o l l a g e n
interactions, and their expression and utilization of KLK5,
as summarized in the model shown in Figure 7(c)(ii). An
invasion-suppressor role for α2 is supported by several lines
of evidence that implicate α2 in the regulation of cellular
homeostasis and diﬀerentiation. Indeed, the α2 integrin has
been linked to the maintenance of tissue architecture [16]
and the orderly proliferation of normal mammary epithelial
cells [9], and a generalized loss of expression has been
noted during breast tumor progression in situ [17, 18].
More importantly, reexpression of α2i na ne n d o g e n o u s l y
α2-negativepoorlydiﬀerentiatedbreastadenocarcinomaline
promoted a diﬀerentiated epithelial morphology with con-
comitantly enhanced branching morphogenesis and restora-
tion of contact inhibition of growth in vitro and reduced
tumor growth in vivo [16]. Reciprocal suppression of α2
expression in endogenously α2-positive well-diﬀerentiated
breast carcinoma cells retarded branching morphogenesis
in a level of expression-dependent manner [16]. Branching
morphogenesis has since been shown to be α2-dependent
using an immortalized, nonmalignant breast epithelial line
[16]. These data suggest that α2 may actually function as
a type of tumor suppressor in the ductal epithelium of the
breast.
Importantly, high α2 expression has been associated
with the orderly proliferation of normal epithelial cells of
several tissues [9], and loss of α2 retards cyst formation
and branching morphogenesis of MDCK epithelial cells
[19], consistent with a role in regulating the diﬀerentiated
epithelial state. Reduced α2β1 expression is also signiﬁcantly
associatedwithDuke’sstageincoloncarcinoma[20].Indeed,
on the basis of a review of the literature, decreased α2
expression has been proposed as the single most common
change in integrin expression in epithelial malignancies
[16]. On the other hand, α2 expression was linked to
poor survival in patients with advanced melanoma [21],
and α2β1 signaling promotes growth of human prostate
cancer cells within bone [22], highlighting the complex
nature of α2β1’s role in tumor biology. Indeed, high α2
expression promoted collagenI adhesion and migration, as
well as invasion of osteosarcoma cells; however, ectopic
expression of α2 did not support growth of these cells in
animals [23]. In PDAC, α2β1 expression has been observed
in normal and well-diﬀerentiated tumors, and although a
generalized loss of α2β1 expression has not been reported in
more progressed lesions in situ, decreased expression and/or
changes in subcellular localization have been described [3–
5, 7, 8]. Herein, we demonstrate that reduced expression
and/or absence of α2b yp o o r l yd i ﬀerentiated PDAC cells is
relatively common in situ and that this often occurs in the
context of adjacent strongly α2-positive more diﬀerentiated
PDAC cells. More importantly, our in vitro ﬁndings provide
a potential explanation for the fact that such a generalized
loss of expression has not been reported more consistently.
In more progressed lesions, the presence of α2 integrin
may not be indicative of its utilization, as noted for the
poorly diﬀerentiated PT45P1 cells, which maintain strong
α2 expression, yet are not dependent upon it for collagen
interactions or invasion.
Although α2 has been implicated as a potential tumor
suppressor in the breast, it has not been speciﬁcally shown to
regulate invasion per se. In our system, reexpression of the α2
integrin promotes interaction with collagens, however such
reexpression actually reduced cellular invasion in vitro. This
phenotype, and the accompanying gene expression changes
that result from stable α2 expression, is exacerbated by
maintenance of the cells on collagen in culture, a surrogate
for exposure to the signiﬁcant desmoplasia characteristic of
PDAC in situ. It should be noted that although mainte-
nance on collagenI has been shown to upregulate total α2
levels in endogenously α2-positive PDAC cells previously
[24], the dynamic regulation of α2 expression observed
in stable MP2-α2 transfectants in response to culture on
collagenI is not likely the result of transcription from the
endogenous promoter, as the Aﬀymetrix analysis failed toJournal of Oncology 13
identify α2 expression in any of the cells (the transgene
construct lacks the 3
 -UTR sequences used as probes in
the analysis). Thus, protein turnover or similar mechanism
may be responsible for the altered α2l e v e l so b s e r v e d .M o r e
importantly, although the net cellular phenotype appears
to be something of a dose-dependent eﬀect (i.e., related to
the α2 levels of the cells), the data shown in Figure 2(d)(ii)
clearly show that α2 levels in the MP2-α2/CI cells removed
from collagenI culture have returned to those observed in
the MP2-α2/TC cells prior to the loss of invasion diﬀerences
shown in Figure 3(a)(iv). This suggests that the eﬀect on
phenotype is more complex, and not solely due to the α2
expression level. Moreover, we did not identify any changes
in α1, α3, α10, or α11 expression as a result of either
stable α2 expression, or long-term interaction of the cells
with collagenI, as noted in Figure 2(c)(i) and the Aﬀymetrix
results. Therefore, the phenotype observed is likely the direct
result of α2 and downstream events reliant on continued α2
expression and/or engagement.
Mechanistically, loss of α2b yp o o r l yd i ﬀerentiated PDAC
cells would release their adhesive constraints within the
collagen-rich desmoplasia of their primary site and may
allow the cells to invade around, rather than through
the collagen-rich matrix. This potentially unintentional
capacity would mimic that of keratinocytes during their re-
epithelialization of wound areas. Both resting and activated
keratinocytes lack αvβ3 integrin expression, and thus do
not interact with ﬁbrin or ﬁbrinogen [25]. This provides
a mechanism for promoting their migration and invasion
around, rather than into, the ﬁbrin clot, through the
collagen-rich dermal wound margin and over ﬁbronectin-
rich granulation tissue. The antiadhesive nature of ﬁbrin in
this case provides the fundamental mechanism whereby the
invading epidermis dissects the ﬁbrin clot from the healing
wound, resulting in an appropriately structured epidermis
in place of the wound closure. In an analogous, albeit
potentially disorganized manner, highly invasive, poorly
diﬀerentiated, α2-negative PDAC cells may thus ignore the
collagen matrix, and rather interact with other components
such as laminin-5 (laminin-332), which has been shown
to regulate migration of pancreatic tumor cells [26]. A
similar mechanism has been demonstrated for ﬁbroblast
transmigration from collagenous stroma into the ﬁbrin clot
provisional matrix along ﬁbronectin conduits [27]. Indeed,
we observed altered adhesion (Figure 3(g)) and migration
(not shown) on non-α2 matrix proteins in these cells,
consistent with such a mechanism.
It is interesting to note that KLK-5, 6, and 7 expression
is coordinately regulated by α2 in the PDAC system. In
all cases, no other KLKs were aﬀected, and all 3 KLKs
were regulated in the same manner. Indeed, the PDAC lines
examined demonstrate all or nothing expression of these
KLKs, suggesting a coordinated regulation of KLK-5, 6 and 7
expressionthatmayatleastpartlyinvolveα2.KLKexpression
is cell- and tissue-dependent [28], and although KLK6 and
KLK7 have been suggested to promote tumor cell invasion
[14, 29, 30], loss of KLK5 has been observed in prostate
[31], lung [32], breast [33], testicular [34], and renal cancer
tissues [35] versus their normal counterparts, similar to our
PDAC data presented herein. Based on the fact that KLK5 is
expressed by more poorly-invasive PDAC cell lines, the fact
that KLK blockade enhanced the invasion of KLK-positive
cells to the exclusion of KLK-negative cells, and the fact
that ectopic expression of KLK5 decreased invasion and
collagenI migration of endogenously α2-positive PDAC cells,
KLK5 appears to function in an anti-invasive manner in the
PDAC system. Mechanistically, the negative eﬀect of KLK5
oninvasionlikelyreﬂectsitsnegativeinﬂuenceonmigration,
as KLK blockade promoted enhanced collagenI migration by
KLK5-positive cells (Figure 4(c)).
Importantly, KLK5 was upregulated in MP2-α2Δ cells in
comparison to MP2-α9α2 cells, suggesting that at least part
of the invasion suppressor function of the α2-ectodomain
is through modulation of KLK5 expression and that the
α2 cytoplasmic domain retards invasion through regulation
of other mediators. While the α2 cytoplasmic domain is
dispensable for breast cancer cell adhesion to collagenI
[36], spreading was compromised in that system. We did
not observe such an eﬀect, nor did the MP2-α2Δ cells
demonstrate retarded collagenI migration (not shown).
The α2-cytoplasmic domain is, however, required for EGF-
induced chemotactic migration of mammary epithelial cells
oncollagenI[37].Thus,thehaptotacticresponsetocollagenI
measured in our system is likely independent of the growth-
factor input that drives α2-cytoplamic domain-dependent
chemotactic migration in breast cancer cells.
Although we show that α2 is a speciﬁc regulator of
invasion in PDAC cells, there is evidence that the α2 integrin
might function as a negative regulator of malignancy in
other ways. Indeed, α2 signaling sensitizes MCF-7 and
HepG2 cells deprived of matrix interactions to programmed
cell death [38], suggesting that loss of α2 might be ben-
eﬁcial for a tumor cell that is disseminating into new
tissue environments where matrix interactions may not
be consistent. Mechanistically, ErbB2 and v-ras-mediated
downregulation of α2-integrin expression has been shown
to require the Sp1 transcription factor in human breast
epithelial cells [39], an event that was tied to the disruption
of tissue architecture observed in breast cancer. Previously
we demonstrated the loss of syk tyrosine kinase associated
with progression to poorly diﬀerentiated grade PDAC in
vitro and in situ [12]. Syk has been shown to regulate Sp1
transcription factor activity in breast cancer cells; therefore,
loss of syk may predispose breast epithelial cells to ErbB2-
mediated downregulation of α2 integrin, resulting in a
further step along the progression pathway. ErbB2 has also
been implicated in PDAC malignancy [40]; therefore, it
is possible that syk-dependent regulation of Sp1-mediated
α2 integrin expression could serve as a switch in PDAC
progression. Since over 6,000 transcripts were signiﬁcantly
aﬀected by α2 in our system, the ramiﬁcations of such a
switch could be dramatic.
Based on previous publications, the α2 integrin is clearly
involved in mediating collagen interactions of well- to
moderately diﬀerentiated PDAC cells, and indeed, has been
suggested to mediate the malignancy of these cells [6].
However, while the α2 integrin does appear to mediate
collagen adhesion and migration of some α2-positive PDAC14 Journal of Oncology
cells, we provide evidence that reliance on the α2 integrin
is progressively lost during PDAC “dediﬀerentiation”. Since
α2-negative/independent cells demonstrate higher in vitro
invasion and more pronounced distant dissemination in
animals than their α2-dependent counterparts [10, 41], we
propose that loss of α2 expression or utilization would
promote the invasive phenotype in PDAC, at least partly
through the regulation of KLK5 expression. Moreover, the
α2-mediated regulation of gene products associated with
invasion and dissemination indicates that α2l i k e l yi m p a c t s
tumor progression via both direct and indirect mechanisms.
Further studies on the basis of these ﬁndings will investigate
both avenues as well as the role of this integrin in regulating
PDAC dissemination in an orthotopic animal model.
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